Edwards Lifesciences Corp. unveiled a new option in its heart valve franchise on Tuesday. The Irvine-based valve maker’s Ascendra procedure uses an aortic heart valve replacement system that is less ...

An analyst earlier this month took aim at what’s behind a big run-up in shares of Irvine medical device maker Edwards Lifesciences Corp.: a new type of heart valve that doesn’t require major surgery.

IRVINE, CA. -- Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received CE Mark in Europe for valve-in-valve ...

Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up market rivalry with Abbott. Edwards’ device, dubbed Sapien M3, is the first ...

NEW ORLEANS, April 3 (Reuters) - A heart valve replacement technique developed by Edwards LifeSciences Corp <EW.N> that spares patients open-heart surgery had a slightly lower death rate at one year, ...

TORONTO, ON -- Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced that three-year clinical outcomes of its EDWARDS INTUITY ...

Edwards Lifesciences has secured European approval for its transcatheter tricuspid valve replacement system, which the company described as the first minimally invasive therapy of its kind to receive ...

WASHINGTON (Reuters) - The minimally invasive aortic heart valve replacement system from Edwards Lifesciences Corp performed better than a rival product sold by Medtronic Inc in the first head-to-head ...

CHICAGO (Reuters) - Edwards LifeSciences Corp's less-invasive replacement heart valve alleviates symptoms such as fatigue and breathlessness better than standard medical therapy, data released on ...

VANCOUVER, Wash. (AP) — Glenn Baker was just 32 years old when he underwent a relatively new surgical procedure in 1966 to replace a heart valve. This week, the 82-year-old and his family will ...